Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Pharmacol Res ; 110: 151-158, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-27154553

RESUMEN

Social play behaviour is a vigorous form of social interaction, abundant during the juvenile and adolescent phases of life in many mammalian species, including humans. Social play is highly rewarding and it is important for social and cognitive development. Being a rewarding activity, social play can be dissociated in its pleasurable and motivational components. We have previously shown that endocannabinoids modulate the expression of social play behaviour in rats. In the present study, we investigated whether endocannabinoids modulate the motivational and pleasurable properties of social play behaviour, using operant and place conditioning paradigms, respectively. Treatment with the anandamide hydrolysis inhibitor URB597 did not affect operant responding or social play-induced conditioned place preference (CPP) when administered at a dose (0.1mg/kg) known to increase the expression of social play behaviour, while it modestly reduced operant responding at a higher dose (0.2mg/kg). The cannabinoid-1 (CB1) receptor antagonist rimonabant reduced operant responding when administered at a dose (1mg/kg) known to decrease the expression of social play behaviour, although this effect may be secondary to concurrent drug-induced stereotypic behaviours (i.e., grooming and scratching). These data demonstrate that enhancing endocannabinoid levels does not differentially affect the motivational and pleasurable aspects of social play behaviour, whereas CB1 receptor blockade reduces the motivational aspects of social play behaviour, possibly due to response competition. Thus, endocannabinoids likely drive the expression of social play behaviour as a whole, without differentially affecting its motivational or pleasurable properties.


Asunto(s)
Conducta Animal , Encéfalo/metabolismo , Endocannabinoides/metabolismo , Motivación , Juego e Implementos de Juego , Placer , Conducta Social , Amidohidrolasas/antagonistas & inhibidores , Amidohidrolasas/metabolismo , Animales , Conducta Animal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Antagonistas de Receptores de Cannabinoides/farmacología , Condicionamiento Operante , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Masculino , Motivación/efectos de los fármacos , Placer/efectos de los fármacos , Ratas Wistar , Receptor Cannabinoide CB1/antagonistas & inhibidores , Receptor Cannabinoide CB1/metabolismo , Transducción de Señal , Factores de Tiempo
2.
Neuropsychopharmacology ; 41(3): 858-68, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26174597

RESUMEN

Social play behavior, abundant in the young of most mammalian species, is thought to be important for social and cognitive development. Social play is highly rewarding, and as such, the expression of social play depends on its pleasurable and motivational properties. Since the motivational properties of social play have only sporadically been investigated, we developed a setup in which rats responded for social play under a progressive ratio schedule of reinforcement. Dopaminergic neurotransmission plays a key role in incentive motivational processes, and both dopamine and noradrenaline have been implicated in the modulation of social play behavior. Therefore, we investigated the role of dopamine and noradrenaline in the motivation for social play. Treatment with the psychostimulant drugs methylphenidate and cocaine increased responding for social play, but suppressed its expression during reinforced play periods. The dopamine reuptake inhibitor GBR-12909 increased responding for social play, but did not affect its expression, whereas the noradrenaline reuptake inhibitor atomoxetine decreased responding for social play as well as its expression. The effects of methylphenidate and cocaine on responding for social play, but not their play-suppressant effects, were blocked by pretreatment with the dopamine receptor antagonist α-flupenthixol. In contrast, pretreatment with the α2-adrenoceptor antagonist RX821002 prevented the play-suppressant effect of methylphenidate, but left its effect on responding for social play unaltered. In sum, the present study introduces a novel method to study the incentive motivational properties of social play behavior in rats. Using this paradigm, we demonstrate dissociable roles for dopamine and noradrenaline in social play behavior: dopamine stimulates the motivation for social play, whereas noradrenaline negatively modulates the motivation for social play behavior and its expression.


Asunto(s)
Dopamina/metabolismo , Motivación/fisiología , Norepinefrina/metabolismo , Conducta Social , Inhibidores de Captación Adrenérgica/farmacología , Antagonistas de Receptores Adrenérgicos alfa 2/farmacología , Animales , Clorhidrato de Atomoxetina/farmacología , Cocaína/farmacología , Condicionamiento Operante/efectos de los fármacos , Condicionamiento Operante/fisiología , Antagonistas de Dopamina/farmacología , Inhibidores de Captación de Dopamina/farmacología , Flupentixol/farmacología , Idazoxan/análogos & derivados , Idazoxan/farmacología , Masculino , Metilfenidato/farmacología , Motivación/efectos de los fármacos , Pruebas Neuropsicológicas , Piperazinas/farmacología , Distribución Aleatoria , Ratas Wistar , Receptores Adrenérgicos alfa 2/metabolismo , Receptores Dopaminérgicos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA